People

Showing 1565 People
Sort by:
  • Dr Eli Kotler

    Dr Eli Kotler

    Melbourne, Victoria, Australia

  • WP Kerns

    WP Kerns

    Gamma hydroxybutyric acid (GHB) intoxication

  • P Palatini

    P Palatini

    Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers

  • R Padrini

    R Padrini

    Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers

  • GP Galloway

    GP Galloway

    Abuse and therapeutic potential of gamma-hydroxybutyric acid

  • MA Wilson

    MA Wilson

    (±3, 4-Methylenedioxymethamphetamine Selectively Damages Central Serotonergic Neurons in Nonhuman Primates

  • M Kaelen

    M Kaelen

    The paradoxical psychological effects of lysergic acid diethylamide (LSD)

  • H Weinstein

    H Weinstein

    Antagonism of histamine-activated adenylate cyclase in brain by D-lysergic acid diethylamide

  • SH Snyder

    SH Snyder

    Multiple serotonin receptors: differential binding of 5-hydroxytryptamine, lysergic acid diethylamide and spiroperidol • Serotonin and lysergic acid diethylamide binding in rat brain membranes: relationship to postsynaptic serotonin receptors • Stereospecific binding ofd-lysergic acid diethylamide (LSD) to brain membranes: relationship to serotonin receptors • Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain

  • DR Stanski

    DR Stanski

    Pharmacodynamic modeling of the EEG effects of ketamine and its enantiomers in man

  • F Vieira

    F Vieira

    Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority …

  • RI Memon

    RI Memon

    Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review

  • S Naveed

    S Naveed

    Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review

  • A Fida

    A Fida

    Effectiveness and Safety of Ketamine for Unipolar Depression: a Systematic Review

  • GC Leal

    GC Leal

    Intravenous arketamine for treatment-resistant depression: Open-label pilot study • Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority …

  • ID Bandeira

    ID Bandeira

    Intravenous arketamine for treatment-resistant depression: Open-label pilot study

  • David Luke

    David Luke

    University of Greenwich

  • Reid Robinson

    Reid Robinson

    Provo, Utah, USA

    Novamind

  • Doug Drysdale

    Doug Drysdale

    Boston, Massachusetts, USA

    Cybin

  • Rakesh Jain

    Rakesh Jain

    Austin, Texas, USA

    WILD 5 Wellness

  • Saundra Jain

    Saundra Jain

    Austin, Texas, USA

    WILD 5 Wellness

  • Blake Mycoskie

    Blake Mycoskie

    Los Angeles, California, USA

  • Tim Ferriss

    Tim Ferriss

    Austin, Texas, USA

  • Sean Trigony

    Sean Trigony

    Los Angeles, California, USA

    Seven Hound Ventures

  • Tomi Rantamäki